ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000271825.1	Avagacestat	Bladder urothelial carcinoma	0.009238003	Resistant
ENSG00000271825.1	Avagacestat	Kidney renal clear cell carcinoma	0.029343703	Sensitive